Hepatitis C virus (HCV) infection: A systemic disease

Molecular Aspects of Medicine

Volumn 29, Issue 1-2, 2008, Pages 85-95

  Craxì, Antonio ^a   Laffi, Giacomo ^b   Zignego, Anna Linda ^b  

^a Policlinico   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Chronic hepatitis; Extrahepatic manifestations; HCV; Lymphoma; Lymphoproliferative disorders; Mixed cryoglobulinemia

Indexed keywords

ANTIVIRUS AGENT; CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; INTERFERON; PEGINTERFERON; RIBAVIRIN; RITUXIMAB;

CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MONOCLONAL IMMUNOGLOBULINEMIA; MONOTHERAPY; NONHODGKIN LYMPHOMA; PERIPHERAL NEUROPATHY; PLASMAPHERESIS; REVIEW; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT;

CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LYMPHOMA; MODELS, BIOLOGICAL;

HEPATITIS C VIRUS;

EID: 39849110713     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mam.2007.09.017     Document Type: Review

References (95)

1. Agnello V., Chung R.T., and Kaplan L.M. A role for hepatitis C virus infection in type II cryoglobulinemia. New Engl. J. Med. 327 (1992) 1490-1495 see comments
2. Alberti A., Morsica G., Chemello L., Cavalletto D., Noventa F., Pontisso P., and Ruol A. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV. Lancet 340 (1992) 697-698
3. Alter M.J., Margolis H.S., Krawczynski K., Judson F.N., Mares A., Alexander W.J., Hu P.Y., Miller J.K., Gerber M.A., Sampliner R.E., et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties chronic non-A, non-B hepatitis study team. New Engl. J. Med. 327 (1992) 1899-1905
4. Alter M.J., Kruszon-Moran D., Nainan O.V., McQuillan G.M., Gao F., Moyer L.A., Kaslow R.A., and Margolis H.S. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. New Engl. J. Med. 341 (1999) 556-562
5. Andreone P., Zignego A.L., Cursaro C., Gramenzi A., Gherlinzoni F., Fiorino S., Giannini C., Boni P., Sabattini E., Pileri S., Tura S., and Bernardi M. Prevalence of monoclonal gammopathies in patients with hepatitis C virus infection. Ann. Intern. Med. 129 (1998) 294-298
6. Antonelli A., Ferri C., Fallahi P., Pampana A., Ferrari S.M., Goglia F., and Ferrannini E. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 28 (2005) 2548-2550
7. Australian census, 2001, total population: (accessed July 25, 2005).
8. Berg T., von Wagner M., Nasser S., Sarrazin C., Heintges T., Gerlach T., Buggisch P., Goeser T., Rasenack J., Pape G.R., Schmidt W.E., Kallinowski B., Klinker H., Spengler U., Martus P., Alshuth U., and Zeuzem S. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 130 (2006) 1086-1097
9. Boddi M., Abbate R., Chellini B., Giusti B., Solazzo V., Sofi F., Pratesi G., Pratesi C., Gensini G.F., and Zignego A.L. HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques. Digestive and Liver Diseases 39 (2007) 54-59
10. Brouet J.C., Clauvel J.P., Danon F., Klein M., and Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am. J. Med. 57 (1974) 775-788
11. Bruce M.G., Bruden D., McMahon B.J., Christensen C., Homan C., Sullivan D., Deubner H., Hennessy T., Williams J., Livingston S., and Gretch D. Hepatitis C infection in Alaska Natives with persistently normal, persistently elevated or fluctuating alanine aminotransferase levels. Liver Int. 26 (2006) 643-649
12. Cacoub P., Poynard T., Ghillani P., Charlotte F., Olivi M., Piette J.C., and Opolon P. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 42 (1999) 2204-2212
13. Chevaliez S., and Pawlotsky J.M. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J. Gastroenterol. 13 (2007) 2461-2466
14. Cribier B., Garnier C., Laustriat D., and Heid E. Lichen planus and hepatitis C virus infection: an epidemiologic study. J. Am. Acad. Dermatol. 31 (1994) 1070-1072
15. Davis G.L., Albright J.E., Cook S.F., and Rosenberg D.M. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 9 (2003) 331-338
16. Davis G.L., Wong J.B., McHutchison J.G., Manns M.P., Harvey J., and Albrecht J. Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C. Hepatology 38 (2003) 645-652
17. De Vita S., Sacco C., Sansonno D., Gloghini A., Dammacco F., Crovatto M., Santini G., Dolcetti R., Boiocchi M., Carbone A., and Zagonel V. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 90 (1997) 776-782
18. Dwight M.M., Kowdley K.V., Russo J.E., Ciechanowski P.S., Larson A.M., and Katon W.J. Depression, fatigue, and functional disability in patients with chronic hepatitis C. J. Psychosom. Res. 49 (2000) 311-317
19. Ferenci P., Fried M.W., Shiffman M.L., Smith C.I., Marinos G., Goncales Jr. F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Chaneac M., and Reddy K.R. Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin. J. Hepatol. 43 (2005) 425-433
20. Ferri C., and Zignego A.L. Relation between infection and autoimmunity in mixed cryoglobulinemia. Curr. Opin. Rheumatol. 12 (2000) 53-60
21. Ferri C., La Civita L., Cirafisi C., Siciliano G., Longombardo G., Bombardieri S., and Rossi B. Peripheral neuropathy in mixed cryoglobulinemia: clinical and electrophysiologic investigations. J. Rheumatol. 19 (1992) 889-895
22. Ferri C., Marzo E., Longombardo G., Lombardini F., La Civita L., Vanacore R., Liberati A.M., Gerli R., Greco F., Moretti A., and Zignego A.L. Interferon-alpha in mixed cryoglobulinemia patients: a randomized, crossover-controlled trial. Blood 81 (1993) 1132-1136
23. Ferri C., Monti M., La Civita L., Longombardo G., Greco F., Pasero G., Gentilini P., Bombardieri S., and Zignego A.L. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 82 (1993) 3701-3704
24. Ferri C., Zignego A.L., Longombardo G., Monti M., La Civita L., Lombardini F., Greco F., Mazzoni A., Pasero G., Gentilini P., et al. Effect of alpha-interferon on hepatitis C virus chronic infection in mixed cryoglobulinemia patients. Infection 21 (1993) 93-97
25. Ferri C., Caracciolo F., La Civita L., Monti M., Longombardo G., Greco F., and Zignego A.L. Hepatitis C virus infection and B-cell lymphomas. Eur J Cancer 10 (1994) 1591-1592 letter
26. Ferri C., Caracciolo F., Zignego A.L., La Civita L., Monti M., Longombardo G., Lombardini F., Greco F., Capochiani E., Mazzoni A., et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Brit. J. Haematol. 88 (1994) 392-394
27. Ferri C., La Civita L., Caracciolo F., and Zignego A.L. Non-Hodgkin's lymphoma: possible role of hepatitis C virus. Jama 272 (1994) 355-356 letter
28. Ferri C., Monti M., La Civita L., Careccia G., Mazzaro C., Longombardo G., Lombardini F., Greco F., Pasero G., Bombardieri S., and Zignego A.L. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. Eur. J. Clin.; Invest 24 (1994) 781-784
29. Ferri C., La Civita L., Longombardo G., Zignego A.L., and Pasero G. Mixed cryoglobulinaemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 7 (1998) 275-279
30. Ferri, C., Pileri, S., Zignego, A.L. 2000. Infectious causes of cancer. Targets for intervention. Geodert, J., (Nih) Nci (Eds.), The Human Press inc.: Totowa, New Jersey, pp. 349-68.
31. Ferri C., Bertozzi M.A., and Zignego A.L. Erectile dysfunction and hepatitis C virus infection. Jama 288 (2002) 698-699
32. Ferri C., Zignego A.L., and Pileri S.A. Cryoglobulins. J. Clin. Pathol. 55 (2002) 4-13
33. Ferri C., Sebastiani M., Giuggioli D., Cazzato M., Longombardo G., Antonelli A., Puccini R., Michelassi C., and Zignego A.L. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin. Arthritis Rheum. 33 (2004) 355-374
34. Ferri C., Zignego A.L., and Pileri S.A. Cryoglobulinemia (2006), Elsevier, Philadelphia (PA)
35. Forton D.M., Thomas H.C., Murphy C.A., Allsop J.M., Foster G.R., Main J., Wesnes K.A., and Taylor-Robinson S.D. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 35 (2002) 433-439
36. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. New Engl. J. Med. 347 (2002) 975-982
37. Giannelli F., Moscarella S., Giannini C., Caini P., Monti M., Gragnani L., Romanelli R.G., Solazzo V., Laffi G., La Villa G., Gentilini P., and Zignego A.L. Effect of antiviral treatment in patients with chronic HCV infection and t(14;18) translocation. Blood 102 (2003) 1196-1201
38. Giannini C., Giannelli F., and Linda Zignego A. Association between mixed cryoglobulinemia, translocation (14;18), and persistence of occult HCV lymphoid infection after treatment. Hepatology 43 (2006) 1166-1167
39. Gorevic P.D., Kassab H.J., Levo Y., Kohn R., Meltzer M., Prose P., and Franklin E.C. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am. J. Med. 69 (1980) 287-308
40. Gretch D.R. Diagnostic tests for hepatitis C. Hepatology 26 (1997) 43S-47S
41. Haddad J., Deny P., Munz-Gotheil C., Ambrosini J.C., Trinchet J.C., Pateron D., Mal F., Callard P., and Beaugrand M. Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339 (1992) 321-323
42. Hayashi J., Nakashima K., Yoshimura E., Hirata M., Maeda Y., and Kashiwagi S. Detection of HCV RNA in subjects with antibody to hepatitis C virus among the general population of Fukuoka, Japan. J. Gastroenterol. 29 (1994) 147-151
43. Hermine O., Lefrere F., Bronowicki J.P., Mariette X., Jondeau K., Eclache-Saudreau V., Delmas B., Valensi F., Cacoub P., Brechot C., Varet B., and Troussard X. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. New Engl. J. Med. 347 (2002) 89-94
44. Ishizaka N., Ishizaka Y., Takahashi E., Tooda E., Hashimoto H., Nagai R., and Yamakado M. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 359 (2002) 133-135
45. Ito S., Ito M., Cho M.J., Shimotohno K., and Tajima K. Massive sero-epidemiological survey of hepatitis C virus: clustering of carriers on the southwest coast of Tsushima, Japan. Jpn. J. Cancer Res. 82 (1991) 1-3
46. Jauncey M., Micallef J.M., Gilmour S., Amin J., White P.A., Rawlinson W., Kaldor J.M., van Beek I., and Dore G.J. Clearance of hepatitis C virus after newly acquired infection in injection drug users. J. Infect. Dis. 190 (2004) 1270-1274
47. Jensen D.M., Morgan T.R., Marcellin P., Pockros P.J., Reddy K.R., Hadziyannis S.J., Ferenci P., Ackrill A.M., and Willems B. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy. Hepatology 43 (2006) 954-960
48. Johnson R.J., Gretch D.R., Yamabe H., Hart J., Bacchi C.E., Hartwell P., Couser W.G., Corey L., Wener M.H., Alpers C.E., et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. New Engl. J. Med. 328 (1993) 465-470 see comments
49. Kayali Z., Buckwold V.E., Zimmerman B., and Schmidt W.N. Hepatitis C, cryoglobulinemia, and cirrhosis: a meta-analysis. Hepatology 36 (2002) 978-985
50. Knobler H., Schihmanter R., Zifroni A., Fenakel G., and Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin. Proc. 75 (2000) 355-359
51. Kondili L.A., Chionne P., Costantino A., Villano U., Lo Noce C., Pannozzo F., Mele A., Giampaoli S., and Rapicetta M. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 50 (2002) 693-696
52. Kwiatkowski C.F., Fortuin Corsi K., and Booth R.E. The association between knowledge of hepatitis C virus status and risk behaviors in injection drug users. Addiction 97 (2002) 1289-1294
53. Lauer G.M., and Walker B.D. Hepatitis C virus infection. New Engl. J. Med. 345 (2001) 41-52
54. Law M.G., Dore G.J., Bath N., Thompson S., Crofts N., Dolan K., Giles W., Gow P., Kaldor J., Loveday S., Powell E., Spencer J., and Wodak A. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. Int. J. Epidemiol. 32 (2003) 717-724
55. Lidove O., Cacoub P., Maisonobe T., Servan J., Thibault V., Piette J.C., and Leger J.M. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann. Rheum. Dis. 60 (2001) 290-292
56. Lunel F., Musset L., Cacoub P., Frangeul L., Cresta P., Perrin M., Grippon P., Hoang C., Valla D., Piette J.C., et al. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106 (1994) 1291-1300
57. Luppi M., Grazia Ferrari M., Bonaccorsi G., Longo G., Narni F., Barozzi P., Marasca R., Mussini C., and Torelli G. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia. Leukemia 10 (1996) 351-355
58. Luppi M., Longo G., Ferrari M.G., Barozzi P., Marasca R., Morselli M., Valenti C., Mascia T., Vandelli L., Vallisa D., Cavanna L., and Torelli G. Clinico-pathological characterization of hepatitis C virus-related B- cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia. Ann. Oncol. 9 (1998) 495-498 see comments
59. Machida K., Cheng K.T., Sung V.M., Shimodaira S., Lindsay K.L., Levine A.M., Lai M.Y., and Lai M.M. Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes. Proc. Natl. Acad. Sci. USA 101 (2004) 4262-4267
60. Magalini A.R., Facchetti F., Salvi L., Fontana L., Puoti M., and Scarpa A. Clonality of B-cells in portal lymphoid infiltrates of HCV-infected livers. J. Pathol. 185 (1998) 86-90
61. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., and Albrecht J.K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358 (2001) 958-965
62. Marcellin P., Boyer N., Gervais A., Martinot M., Pouteau M., Castelnau C., Kilani A., Areias J., Auperin A., Benhamou J.P., Degott C., and Erlinger S. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann. Intern. Med. 127 (1997) 875-881
63. Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., and Mueller N.E. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 95 (2004) 745-752
64. McHutchison J.G., Gordon S.C., Schiff E.R., Shiffman M.L., Lee W.M., Rustgi V.K., Goodman Z.D., Ling M.H., Cort S., and Albrecht J.K. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. New Engl. J. Med. 339 (1998) 1485-1492
65. Mele A., Pulsoni A., Bianco E., Musto P., Szklo A., Sanpaolo M.G., Iannitto E., De Renzo A., Martino B., Liso V., Andrizzi C., Pusterla S., Dore F., Maresca M., Rapicetta M., Marcucci F., Mandelli F., and Franceschi S. Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood 102 (2003) 996-999
66. Meltzer M., Franklin E.C., Elias K., McCluskey R.T., and Cooper N. Cryoglobulinemia-a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am. J. Med. 40 (1966) 837-856
67. Misiani R., Bellavita P., Fenili D., Borelli G., Marchesi D., Massazza M., Vendramin G., Comotti B., Tanzi E., Scudeller G., et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann. Intern. Med. 117 (1992) 573-577
68. Nguyen T.T., Sedghi-Vaziri A., Wilkes L.B., Mondala T., Pockros P.J., Lindsay K.L., and McHutchison J.G. Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection. J. Viral. Hepat. 3 (1996) 75-78
69. Nieters A., Kallinowski B., Brennan P., Ott M., Maynadie M., Benavente Y., Foretova L., Cocco P.L., Staines A., Vornanen M., Whitby D., Boffetta P., Becker N., and De Sanjose S. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology 131 (2006) 1879-1886
70. Palitzsch K.D., Hottentrager B., Schlottmann K., Frick E., Holstege A., Scholmerich J., and Jilg W. Prevalence of antibodies against hepatitis C virus in the adult German population. Eur. J. Gastroenterol. Hepatol. 11 (1999) 1215-1220
71. Pasquariello A., Ferri C., Moriconi L., La Civita L., Longombardo G., Lombardini F., Greco F., and Zignego A.L. Cryoglobulinemic membranoproliferative glomerulonephritis associated with hepatitis C virus. Am. J. Nephrol. 13 (1993) 300-304
72. Pawlotsky J.M., Bouvier-Alias M., Hezode C., Darthuy F., Remire J., and Dhumeaux D. Standardization of hepatitis C virus RNA quantification. Hepatology 32 (2000) 654-659
73. Radkowski M., Gallegos-Orozco J.F., Jablonska J., Colby T.V., Walewska-Zielecka B., Kubicka J., Wilkinson J., Adair D., Rakela J., and Laskus T. Persistence of hepatitis C virus in patients successfully treated for chronic hepatitis C. Hepatology 41 (2005) 106-114
74. Saadoun D., Suarez F., Lefrere F., Valensi F., Mariette X., Aouba A., Besson C., Varet B., Troussard X., Cacoub P., and Hermine O. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?. Blood 105 (2005) 74-76
75. Saadoun D., Asselah T., Resche-Rigon M., Charlotte F., Bedossa P., Valla D., Piette J.C., Marcellin P., and Cacoub P. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C. Hepatology 43 (2006) 1337-1345
76. Sansonno D., De Vita S., Iacobelli A.R., Cornacchiulo V., Boiocchi M., and Dammacco F. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. J. Immunol. 160 (1998) 3594-3601
77. Sansonno D., De Re V., Lauletta G., Tucci F.A., Boiocchi M., and Dammacco F. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20. Blood 101 (2003) 3818-3826
78. Scott J.D., and Gretch D.R. Molecular diagnostics of hepatitis C virus infection: a systematic review. Jama 297 (2007) 724-732
79. Scott J.D., McMahon B.J., Bruden D., Sullivan D., Homan C., Christensen C., and Gretch D.R. High rate of spontaneous negativity for hepatitis C virus RNA after establishment of chronic infection in Alaska Natives. Clin. Infect. Dis. 42 (2006) 945-952
80. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect. Dis. 5 (2005) 558-567
81. Shuhart M.C., Bronner M.P., Gretch D.R., Thomassen L.V., Wartelle C.F., Tateyama H., Emerson S.S., Perkins J.D., and Carithers Jr. R.L. Histological and clinical outcome after liver transplantation for hepatitis C. Hepatology 26 (1997) 1646-1652
82. Silvestri F., Pipan C., Barillari G., Zaja F., Fanin R., Infanti L., Russo D., Falasca E., Botta G.A., and Baccarani M. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 87 (1996) 4296-4301
83. Stehman-Breen C., Alpers C.E., Couser W.G., Willson R., and Johnson R.J. Hepatitis C virus associated membranous glomerulonephritis. Clin. Nephrol. 44 (1995) 141-147
84. Talamini R., Montella M., Crovatto M., Dal Maso L., Crispo A., Negri E., Spina M., Pinto A., Carbone A., and Franceschi S. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int. J. Cancer 110 (2004) 380-385
85. Trabaud M.A., Bailly F., Si-Ahmed S.N., Chevallier P., Sepetjan M., Colucci G., and Trepo C. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon. J. Med. Virol. 52 (1997) 105-112
86. Watanabe H., Saito T., Shinzawa H., Okumoto K., Hattori E., Adachi T., Takeda T., Sugahara K., Ito J.I., Saito K., Togashi H., Suzuki R., Hayashi M., Miyamura T., Matsuura Y., and Kawata S. Spontaneous elimination of serum hepatitis C virus (HCV) RNA in chronic HCV carriers: a population-based cohort study. J. Med. Virol. 71 (2003) 56-61
87. Zaja F., De Vita S., Mazzaro C., Sacco S., Damiani D., De Marchi G., Michelutti A., Baccarani M., Fanin R., and Ferraccioli G. Efficacy and safety of rituximab in type II mixed cryoglobulinemia. Blood 101 (2003) 3827-3834
88. Zignego A.L., and Brechot C. Extrahepatic manifestations of HCV infection: facts and controversies. J. Hepatol. 31 (1999) 369-376
89. Zignego A.L., Ferri C., Giannini C., La Civita L., Careccia G., Longombardo G., Bellesi G., Caracciolo F., Thiers V., and Gentilini P. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non- Hodgkin's lymphoma: evidence for a pathogenetic role. Arch. Virol. 142 (1997) 545-555
90. Zignego A.L., Giannelli F., Marrocchi M.E., Mazzocca A., Ferri C., Giannini C., Monti M., Caini P., Villa G.L., Laffi G., and Gentilini P. T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 31 (2000) 474-479
91. Zignego A.L., Ferri C., Giannelli F., Giannini C., Caini P., Monti M., Marrocchi E.M., Di Pietro E., La Villa G., Laffi G., and Gentilini P. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann. Intern. Med. 137 (2002) 571-580
92. Zignego A.L., Ferri C., Pileri S.A., Caini P., and Bianchi F.B. Extrahepatic manifestations of Hepatitis C virus infection: a general overview and guidelines for a clinical approach. Dig. Liver Dis. 39 (2007) 2-17
93. Zignego A.L., Giannini C., and Ferri C. Hepatitis C virus-related lymphoproliferative disorders: an overview. World J. Gastroenterol. 13 (2007) 2467-2478
94. Zou S., Tepper M., and El Saadany S. Prediction of hepatitis C burden in Canada. Can. J. Gastroenterol. 14 (2000) 575-580
95. Zuckerman E., Zuckerman T., Sahar D., Streichman S., Attias D., Sabo E., Yeshurun D., and Rowe J.M. The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 97 (2001) 1555-1559